Bachisio Ziccheddu

1.6k total citations
33 papers, 409 citations indexed

About

Bachisio Ziccheddu is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Bachisio Ziccheddu has authored 33 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 20 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Bachisio Ziccheddu's work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (16 papers) and CAR-T cell therapy research (9 papers). Bachisio Ziccheddu is often cited by papers focused on Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (16 papers) and CAR-T cell therapy research (9 papers). Bachisio Ziccheddu collaborates with scholars based in United States, Italy and Canada. Bachisio Ziccheddu's co-authors include Niccolò Bolli, Francesco Maura, Ola Landgren, Carolina Terragna, Marina Martello, Xosé S. Puente, Elı́as Campo, Stefania Oliva, Ferran Nadeu and Elisa Genuardi and has published in prestigious journals such as Nature Communications, Blood and Clinical Cancer Research.

In The Last Decade

Bachisio Ziccheddu

30 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bachisio Ziccheddu United States 11 260 253 175 97 66 33 409
Phaik Ju Teoh Singapore 8 294 1.1× 175 0.7× 189 1.1× 39 0.4× 31 0.5× 15 406
Santiago Barrio Spain 13 359 1.4× 320 1.3× 169 1.0× 68 0.7× 84 1.3× 37 521
Donata Verdelli Italy 10 398 1.5× 346 1.4× 145 0.8× 67 0.7× 75 1.1× 14 532
Mayumi Sugita United States 12 193 0.7× 240 0.9× 141 0.8× 23 0.2× 27 0.4× 24 482
Michelle F. Waldman United States 6 441 1.7× 306 1.2× 265 1.5× 34 0.4× 92 1.4× 14 653
Zuzana Chyra Czechia 11 170 0.7× 127 0.5× 109 0.6× 28 0.3× 25 0.4× 31 279
Stéphane Raynaud France 6 236 0.9× 128 0.5× 111 0.6× 115 1.2× 25 0.4× 7 379
Andrea Pepper United Kingdom 8 121 0.5× 96 0.4× 187 1.1× 26 0.3× 42 0.6× 19 348
Greg Ahmann United States 9 435 1.7× 410 1.6× 179 1.0× 48 0.5× 56 0.8× 18 541
Ellen Ingalla United States 5 241 0.9× 127 0.5× 126 0.7× 29 0.3× 49 0.7× 12 339

Countries citing papers authored by Bachisio Ziccheddu

Since Specialization
Citations

This map shows the geographic impact of Bachisio Ziccheddu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bachisio Ziccheddu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bachisio Ziccheddu more than expected).

Fields of papers citing papers by Bachisio Ziccheddu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bachisio Ziccheddu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bachisio Ziccheddu. The network helps show where Bachisio Ziccheddu may publish in the future.

Co-authorship network of co-authors of Bachisio Ziccheddu

This figure shows the co-authorship network connecting the top 25 collaborators of Bachisio Ziccheddu. A scholar is included among the top collaborators of Bachisio Ziccheddu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bachisio Ziccheddu. Bachisio Ziccheddu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tauro, Marilena, Bachisio Ziccheddu, Alexandra M. Poos, et al.. (2024). Replication Stress Induces Hyper-Apobec Mutagenesis in Multiple Myeloma. Blood. 144(Supplement 1). 3276–3276.
2.
Kazandjian, Dickran, Benjamin Diamond, Romanos Sklavenitis‐Pistofidis, et al.. (2024). Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma. Clinical Cancer Research. 30(19). 4482–4490. 5 indexed citations
3.
Maura, Francesco, David G. Coffey, Caleb K. Stein, et al.. (2024). The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans. Nature Communications. 15(1). 3844–3844. 4 indexed citations
4.
Lee, Holly, Michael Durante, Sheri Skerget, et al.. (2024). Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma. Blood. 144(25). 2637–2651. 16 indexed citations
5.
Ziccheddu, Bachisio, Claudia Giannotta, Mattia D’Agostino, et al.. (2024). Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma. Blood Cancer Journal. 14(1). 117–117. 4 indexed citations
6.
Nenarokov, Serafim, Tereza Ševčíková, Jan Vrána, et al.. (2024). Insights into Biological Mechanisms Responsible for Egression of Circulating Tumor Plasma Cells (CTCs) in Multiple Myeloma. Blood. 144(Supplement 1). 3270–3270. 1 indexed citations
7.
Chojnacka, Monika, Benjamin Diamond, Bachisio Ziccheddu, et al.. (2023). Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma. Clinical Cancer Research. 30(3). 575–585. 1 indexed citations
8.
Tauro, Marilena, Bachisio Ziccheddu, Alexandra M. Poos, et al.. (2023). Genomic and Transcriptomic Landscape of Hyper-Apobec Multiple Myeloma. Blood. 142(Supplement 1). 639–639. 1 indexed citations
9.
Diamond, Benjamin, Dickran Kazandjian, Bachisio Ziccheddu, et al.. (2023). Genomic Profiling to Interpret the Outcomes of Early Intervention for High-Risk Smoldering Myeloma. Blood. 142(Supplement 1). 757–757. 1 indexed citations
10.
Coughlin, Carrie C., Yitzhar Goretsky, Arjun R. Sondhi, et al.. (2023). RHOA deficiency drives decreased CD19 expression and immune dysregulation in CAR‐T resistant diffuse large B‐cell lymphoma. Hematological Oncology. 41(S2). 272–273. 1 indexed citations
11.
Maura, Francesco, Alexandra M. Poos, Anthony Cirrincione, et al.. (2023). The Temporal Evolution of Chromosome 1q Gain and Hyperdiploidy and Its Impact on Clinical Outcomes in Multiple Myeloma. Blood. 142(Supplement 1). 638–638. 3 indexed citations
12.
Jain, Michael D., Bachisio Ziccheddu, Caroline A. Coughlin, et al.. (2022). Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma. Blood. 140(5). 491–503. 36 indexed citations
13.
Maclachlan, Kylee, Tina Bagratuni, Efstathios Kastritis, et al.. (2022). Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations. Blood Advances. 7(6). 971–981. 1 indexed citations
14.
Lee, Holly, Paola Neri, Sungwoo Ahn, et al.. (2022). Role of TNFRSF17 and GPRC5D Structural and Point Mutations in Resistance to Targeted Immunotherapies in Multiple Myeloma (MM). Blood. 140(Supplement 1). 252–253. 11 indexed citations
15.
Maclachlan, Kylee, Even H Rustad, Andriy Derkach, et al.. (2021). Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma. Nature Communications. 12(1). 5172–5172. 26 indexed citations
16.
Ziccheddu, Bachisio, Giulia Biancon, Chiara De Philippis, et al.. (2020). Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma. Blood Advances. 4(5). 830–844. 49 indexed citations
17.
D’Agostino, Mattia, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.. (2020). Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. Clinical Cancer Research. 26(18). 4832–4841. 38 indexed citations
18.
Manzoni, Martina, Valentina Marchica, Paola Storti, et al.. (2020). Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma. Cancers. 12(5). 1332–1332. 6 indexed citations
19.
Maura, Francesco, Andrea Degasperi, Ferran Nadeu, et al.. (2019). A practical guide for mutational signature analysis in hematological malignancies. Nature Communications. 10(1). 2969–2969. 99 indexed citations
20.
D’Agostino, Mattia, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.. (2019). Clinical and Biological Early Relapse Predictors in Multiple Myeloma: An Analysis from the MMRF CoMMpass Study. Clinical Lymphoma Myeloma & Leukemia. 19(10). e13–e14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phaik Ju Teoh Breakdown of academic impact, for papers by Santiago Barrio Breakdown of academic impact, for papers by Donata Verdelli Breakdown of academic impact, for papers by Mayumi Sugita Breakdown of academic impact, for papers by Michelle F. Waldman Breakdown of academic impact, for papers by Zuzana Chyra Breakdown of academic impact, for papers by Stéphane Raynaud Breakdown of academic impact, for papers by Andrea Pepper Breakdown of academic impact, for papers by Greg Ahmann Breakdown of academic impact, for papers by Ellen Ingalla
Rankless by CCL
2026